|
IL73534A
(en)
|
1983-11-18 |
1990-12-23 |
Riker Laboratories Inc |
1h-imidazo(4,5-c)quinoline-4-amines,their preparation and pharmaceutical compositions containing certain such compounds
|
|
US5658592A
(en)
|
1994-05-13 |
1997-08-19 |
Kuraray Co., Ltd. |
Medical crosslinked polymer gel of carboxylic polysaccharide and diaminoalkane
|
|
US7662368B2
(en)
|
1999-07-16 |
2010-02-16 |
Institut Pasteur |
Method of inducing SHC phosphorylation of inducing the SHC/MAPK pathway by administering a peptide of IL-2
|
|
KR20030057529A
(ko)
|
2000-09-08 |
2003-07-04 |
그리폰 테라퓨틱스, 인코포레이티드 |
합성 적혈구생성 자극 단백질
|
|
US6441163B1
(en)
|
2001-05-31 |
2002-08-27 |
Immunogen, Inc. |
Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents
|
|
AU2002315414B2
(en)
|
2001-06-21 |
2008-02-07 |
Clontech Laboratories, Inc. |
Water-soluble polymeric metal ion affinity compositions and methods for using the same
|
|
JPWO2003084571A1
(ja)
|
2002-04-08 |
2005-08-11 |
電気化学工業株式会社 |
骨感染症治療用組成物
|
|
US7445894B2
(en)
|
2002-05-03 |
2008-11-04 |
Molecular Probes, Inc. |
Compositions and methods for detection and isolation of phosphorylated molecules
|
|
MXPA05011811A
(es)
|
2003-05-20 |
2006-02-17 |
Immunogen Inc |
Agentes citotoxicos mejorados que comprenden nuevos maitansinoides.
|
|
US20090304587A1
(en)
|
2005-11-01 |
2009-12-10 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Biodegradable composite for internal local radiotherapy
|
|
US7919079B2
(en)
|
2006-03-31 |
2011-04-05 |
Biosante Pharmaceuticals, Inc. |
Cancer immunotherapy compositions and methods of use
|
|
EP2017281A4
(en)
|
2006-04-14 |
2012-03-14 |
Kyowa Hakko Kirin Co Ltd |
AGONISTS AT TOLL-LIKE RECEPTOR 9
|
|
EP1867638A1
(de)
|
2006-06-16 |
2007-12-19 |
Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts |
Verfahren zur kovalenten Verknüpfung zweier Moleküle mittels Diels-Alder-Reaktion mit inversem Elektronenbedarf
|
|
US8398956B2
(en)
|
2007-01-11 |
2013-03-19 |
Immunomedics, Inc. |
In vivo copper-free click chemistry for delivery of therapeutic and/or diagnostic agents
|
|
US8236949B2
(en)
|
2007-07-17 |
2012-08-07 |
University Of Delaware |
Tetrazine-based bio-orthogonal coupling reagents and methods
|
|
KR20100053598A
(ko)
|
2007-08-01 |
2010-05-20 |
이데라 파마슈티칼즈, 인코포레이티드 |
Ｔｌｒ９의 신규한 합성 효능제
|
|
US7732491B2
(en)
|
2007-11-12 |
2010-06-08 |
Bipar Sciences, Inc. |
Treatment of breast cancer with a PARP inhibitor alone or in combination with anti-tumor agents
|
|
WO2011127149A1
(en)
|
2010-04-06 |
2011-10-13 |
University Of Utah Research Foundation |
Controlled release combination biomaterials
|
|
JP5574083B2
(ja)
|
2008-08-01 |
2014-08-20 |
アンタイス エス．エイ． |
高い残留性及び容量を与える高い能力を有する注入可能なヒドロゲル
|
|
US8900549B2
(en)
|
2008-10-31 |
2014-12-02 |
The General Hospital Corporation |
Compositions and methods for delivering a substance to a biological target
|
|
TW201021852A
(en)
|
2008-11-17 |
2010-06-16 |
Enzon Pharmaceuticals Inc |
Releasable fusogenic lipids for nucleic acids delivery systems
|
|
EP2391718A2
(en)
|
2009-01-30 |
2011-12-07 |
Idera Pharmaceuticals, Inc. |
Novel synthetic agonists of tlr9
|
|
CN102395380B
(zh)
|
2009-04-16 |
2015-05-20 |
皇家飞利浦电子股份有限公司 |
预靶向试剂盒、方法和其中使用的试剂
|
|
EP2360167A1
(en)
|
2010-02-03 |
2011-08-24 |
Deutsches Krebsforschungszentrum |
Post-synthetic modification of nucleic acids by inverse Diels-Alder reaction
|
|
US10434197B2
(en)
|
2010-07-23 |
2019-10-08 |
University Of Delaware |
Tetrazine-trans-cyclooctene ligation for the rapid construction of radionuclide labeled probes
|
|
US9463256B2
(en)
|
2010-10-14 |
2016-10-11 |
Koninklijke Philips N.V. |
Pretargeting kit, method and agents used therein
|
|
WO2012074840A2
(en)
|
2010-11-22 |
2012-06-07 |
The General Hospital Corporation |
Compositions and methods for in vivo imaging
|
|
JP5992435B2
(ja)
|
2010-12-21 |
2016-09-14 |
コーニンクレッカ フィリップス エヌ ヴェＫｏｎｉｎｋｌｉｊｋｅ Ｐｈｉｌｉｐｓ Ｎ．Ｖ． |
循環からの生体分子の除去剤
|
|
EP2522369A1
(en)
|
2011-05-09 |
2012-11-14 |
Koninklijke Philips Electronics N.V. |
Pretargeting kit, method and agents used therein
|
|
CA2836338C
(en)
*
|
2011-05-16 |
2022-05-03 |
Koninklijke Philips N.V. |
Tetrazine derivatives used in bio-orthogonal drug activation
|
|
EP2716662A4
(en)
|
2011-05-31 |
2014-11-19 |
Univ Tokyo |
HYDROGEL AND METHOD FOR ITS MANUFACTURE
|
|
ES2393602B1
(es)
|
2011-06-09 |
2013-10-02 |
Universidad Complutense De Madrid |
Materiales biocerámicos para el tratamiento de la osteomielitis.
|
|
WO2013115885A2
(en)
|
2011-11-22 |
2013-08-08 |
The Regents Of The University Of Michigan |
Synthesizing functionalized dendrimers within biological settings
|
|
JP6355563B2
(ja)
|
2012-02-27 |
2018-07-11 |
アムニクス オペレーティング インコーポレイテッド |
Ｘｔｅｎ共役組成物およびそれを製造する方法
|
|
US9206271B2
(en)
|
2012-03-25 |
2015-12-08 |
Wisconsin Alumni Research Foundation |
Fully backbone degradable and functionalizable polymers derived from the ring-opening metathesis polymerization (ROMP)
|
|
WO2013187954A1
(en)
|
2012-06-12 |
2013-12-19 |
The General Hospital Corporation |
Magnetic labeling of bacteria
|
|
WO2014065860A1
(en)
|
2012-10-24 |
2014-05-01 |
The General Hospital Corporation |
Functionalized 1,2,4,5-tetrazine compounds for use in bioorthogonal coupling reactions
|
|
WO2014081300A1
(en)
|
2012-11-22 |
2014-05-30 |
Tagworks Pharmaceuticals B.V. |
Channel protein activatable liposomes
|
|
WO2014081299A1
(en)
|
2012-11-22 |
2014-05-30 |
Tagworks Pharmaceuticals B.V. |
Activatable liposomes
|
|
FI2922574T3
(fi)
|
2012-11-22 |
2023-08-11 |
Tagworks Pharmaceuticals B V |
Kemiallisesti pilkkoutuva ryhmä
|
|
US20150297741A1
(en)
|
2012-11-22 |
2015-10-22 |
Tagworks Pharmaceuticals B.V. |
Bio-orthogonal drug activation
|
|
US9695212B2
(en)
|
2012-12-13 |
2017-07-04 |
Aduro Biotech, Inc. |
Compositions comprising cyclic purine dinucleotides having defined stereochemistries and methods for their preparation and use
|
|
US20150359913A1
(en)
|
2013-01-25 |
2015-12-17 |
Memorial Sloan-Kettering Cancer Center |
Tetrazines/trans-cyclooctenes in solid phase synthesis of labeled peptides
|
|
WO2014138186A1
(en)
|
2013-03-05 |
2014-09-12 |
The Johns Hopkins University |
Bioorthogonal two-component delivery systems for enhanced internalization of nanotherapeutics
|
|
NZ711392A
(en)
|
2013-03-08 |
2020-05-29 |
Polyactiva Pty Ltd |
Polymer conjugate for delivery of a bioactive agent
|
|
PE20160080A1
(es)
|
2013-05-18 |
2016-02-21 |
Aduro Biotech Inc |
Composiciones y metodos para activar la senalizacion que depende del estimulador del gen de interferon
|
|
WO2014189806A1
(en)
|
2013-05-18 |
2014-11-27 |
Aduro Biotech, Inc. |
Compositions and methods for inhibiting "stimulator of interferon gene" dependent signalling
|
|
ES2754177T3
(es)
|
2013-06-12 |
2020-04-16 |
Massachusetts Gen Hospital |
Métodos para la detección multiplexada de moléculas diana y sus usos
|
|
ES2966631T3
(es)
|
2013-06-19 |
2024-04-23 |
Univ California |
Estructuras químicas para el suministro localizado de agentes terapéuticos
|
|
US10046002B2
(en)
|
2013-08-02 |
2018-08-14 |
Syntrix Biosystems Inc. |
Method for treating cancer using chemokine antagonists
|
|
JP2016538344A
(ja)
|
2013-11-19 |
2016-12-08 |
ザ・ユニバーシティ・オブ・シカゴＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃｈｉｃａｇｏ |
癌処置としてのｓｔｉｎｇアゴニストの使用
|
|
HUE045065T2
(hu)
|
2014-01-31 |
2019-12-30 |
Novartis Ag |
TIM-3 antitest molekulák és felhasználásaik
|
|
CA2939265A1
(en)
|
2014-02-10 |
2015-08-13 |
Mcmaster University |
Targeted molecular imaging contrast agents
|
|
CN106659796B
(zh)
|
2014-03-14 |
2021-04-30 |
加利福尼亚大学董事会 |
Tco缀合物和治疗剂递送方法
|
|
KR102442436B1
(ko)
|
2014-03-14 |
2022-09-15 |
노파르티스 아게 |
Lag-3에 대한 항체 분자 및 그의 용도
|
|
ES2951908T3
(es)
|
2014-04-04 |
2023-10-25 |
Harvard College |
Hidrogeles reticulados por química clic y métodos de uso
|
|
US20170119892A1
(en)
|
2014-04-04 |
2017-05-04 |
President And Fellows Of Harvard College |
Refillable drug delivery devices and methods of use thereof
|
|
CR20160564A
(es)
|
2014-06-04 |
2017-01-20 |
Glaxosmithkline Ip Dev Ltd |
Dinucleótidos cíclicos como moduladores de sting
|
|
WO2016014799A1
(en)
|
2014-07-23 |
2016-01-28 |
University Of Iowa Research Foundation |
Epidermal growth factor and blockade of immune checkpoints in cancer immunotherapy
|
|
GB201501462D0
(en)
|
2015-01-29 |
2015-03-18 |
Glaxosmithkline Ip Dev Ltd |
Novel compounds
|
|
EA035817B1
(ru)
|
2015-03-10 |
2020-08-14 |
Адуро Байотек, Инк. |
Композиции и способы для активации сигналинга, зависимого от "гена стимулятора интерферона"
|
|
KR102779525B1
(ko)
|
2015-05-29 |
2025-03-12 |
다이나박스 테크놀로지 코퍼레이션 |
폐암을 치료하기 위한 폴리뉴클레오티드 Toll-유사 수용체 9 아고니스트의 폐내 투여
|
|
US10532056B2
(en)
|
2015-06-29 |
2020-01-14 |
Verastem, Inc. |
Therapeutic compositions, combinations, and methods of use
|
|
KR102222186B1
(ko)
|
2015-08-13 |
2021-03-03 |
머크 샤프 앤드 돔 코포레이션 |
Sting 효능제로서 시클릭 디-뉴클레오티드 화합물
|
|
WO2017044983A1
(en)
|
2015-09-10 |
2017-03-16 |
Shasqi, Inc. |
Bioorthogonal compositions
|
|
JP2018534295A
(ja)
|
2015-10-28 |
2018-11-22 |
アドゥロ バイオテック，インク． |
「インターフェロン遺伝子刺激因子」依存性シグナル伝達を活性化するための組成物および方法
|
|
CN107849084B
(zh)
|
2015-12-03 |
2021-09-14 |
葛兰素史密斯克莱知识产权发展有限公司 |
作为sting调节剂的环状嘌呤二核苷酸
|
|
KR102789862B1
(ko)
|
2016-01-11 |
2025-04-03 |
인네이트 튜머 이뮤니티, 인코포레이티드 |
Sting 활성과 연관된 상태 예컨대 암의 치료를 위한 시클릭 디뉴클레오티드
|
|
JP2019513371A
(ja)
|
2016-04-01 |
2019-05-30 |
アビディティー バイオサイエンシーズ エルエルシー |
核酸ポリペプチド組成物とその使用
|
|
AU2017257254B2
(en)
*
|
2016-04-27 |
2022-02-24 |
Immunomedics, Inc. |
Efficacy of anti-Trop-2-SN-38 antibody drug conjugates for therapy of tumors relapsed/refractory to checkpoint inhibitors
|
|
EP3507367A4
(en)
|
2016-07-05 |
2020-03-25 |
Aduro BioTech, Inc. |
CYCLIC DINUCLEOTID COMPOUNDS WITH INCLUDED NUCLEIC ACIDS AND USES THEREOF
|
|
IL264049B2
(en)
|
2016-07-06 |
2023-11-01 |
Sperovie Biosciences Inc |
Compounds, preparations and methods for treating the disease
|
|
WO2018009652A1
(en)
|
2016-07-06 |
2018-01-11 |
Sperovie Biosciences, Inc. |
Compounds, compositions, and methods for the treatment of disease
|
|
CN109715202A
(zh)
|
2016-07-15 |
2019-05-03 |
斯必乐维生物科学公司 |
用于治疗疾病的化合物、组合物和方法
|
|
WO2018013887A1
(en)
|
2016-07-15 |
2018-01-18 |
Sperovie Biosciences, Inc. |
Compounds, compositions, and methods for the treatment of disease
|
|
US10537590B2
(en)
|
2016-09-30 |
2020-01-21 |
Boehringer Ingelheim International Gmbh |
Cyclic dinucleotide compounds
|
|
PT3523287T
(pt)
|
2016-10-04 |
2021-10-06 |
Merck Sharp & Dohme |
Compostos de benzo[b]tiofeno como agonistas de sting
|
|
JOP20170188A1
(ar)
|
2016-11-25 |
2019-01-30 |
Janssen Biotech Inc |
ثنائي النوكليوتيدات الحلقية كمنبهات ستينغ (sting)
|
|
PE20210255A1
(es)
|
2016-12-01 |
2021-02-10 |
Takeda Pharmaceuticals Co |
Dinucleotido ciclico como agonistas de sting (estimulador de genes de interferon)
|
|
WO2018118665A1
(en)
|
2016-12-20 |
2018-06-28 |
Merck Sharp & Dohme Corp. |
Cyclic dinucleotide sting agonists for cancer treatment
|
|
US11021511B2
(en)
|
2017-01-27 |
2021-06-01 |
Janssen Biotech, Inc. |
Cyclic dinucleotides as sting agonists
|
|
CN110234403A
(zh)
|
2017-01-27 |
2019-09-13 |
詹森生物科技公司 |
作为sting激动剂的环状二核苷酸
|
|
JOP20190218A1
(ar)
|
2017-03-22 |
2019-09-22 |
Boehringer Ingelheim Int |
مركبات ثنائية النيوكليوتيدات حلقية معدلة
|
|
AU2018250312C1
(en)
|
2017-04-07 |
2024-08-22 |
Tambo, Inc. |
Bioorthogonal compositions
|
|
UY37695A
(es)
|
2017-04-28 |
2018-11-30 |
Novartis Ag |
Compuesto dinucleótido cíclico bis 2’-5’-rr-(3’f-a)(3’f-a) y usos del mismo
|
|
US11466047B2
(en)
|
2017-05-12 |
2022-10-11 |
Merck Sharp & Dohme Llc |
Cyclic di-nucleotide compounds as sting agonists
|
|
UA125730C2
(uk)
|
2017-06-22 |
2022-05-25 |
Курадев Фарма Лімітед |
Низькомолекулярні модулятори sting людини
|
|
WO2018234807A1
(en)
|
2017-06-22 |
2018-12-27 |
Curadev Pharma Limited |
Heterocyclic small molecule modulators of human sting
|
|
US20200138827A1
(en)
|
2017-06-22 |
2020-05-07 |
Curadev Pharma Limited |
Small molecule modulators of human sting
|
|
JP2020530838A
(ja)
|
2017-08-04 |
2020-10-29 |
メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． |
がん治療のためのベンゾ［ｂ］チオフェンＳＴＩＮＧアゴニスト
|
|
WO2019046511A1
(en)
|
2017-08-31 |
2019-03-07 |
Sperovie Biosciences, Inc. |
COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASE
|
|
US11584774B2
(en)
|
2017-09-11 |
2023-02-21 |
F-star Therapeutics, Inc. |
Compounds, compositions, and methods for the treatment of disease
|
|
US11707531B2
(en)
|
2017-09-11 |
2023-07-25 |
F-star Therapeutics, Inc. |
Compounds, compositions, and methods for the treatment of disease
|
|
AR114990A1
(es)
|
2017-11-02 |
2020-11-18 |
Alios Biopharma Inc |
Constructos de oligonucleótidos y usos de los mismos
|
|
KR20200098511A
(ko)
|
2017-11-10 |
2020-08-20 |
다케다 야쿠힌 고교 가부시키가이샤 |
Sting 조절제 화합물, 및 제조 및 사용 방법
|
|
CN111712509A
(zh)
|
2017-12-15 |
2020-09-25 |
詹森生物科技公司 |
作为sting激动剂的环状二核苷酸
|
|
CR20200260A
(es)
|
2017-12-15 |
2020-08-01 |
Bayer Animal Health Gmbh |
Composiciones inmunoestimulantes
|
|
EP3728283B1
(en)
|
2017-12-20 |
2023-11-22 |
Institute of Organic Chemistry and Biochemistry ASCR, V.V.I. |
3'3' cyclic dinucleotides with phosphonate bond activating the sting adaptor protein
|
|
EP3727401A4
(en)
|
2017-12-20 |
2022-04-06 |
Merck Sharp & Dohme Corp. |
CYCLIC DI-NUCLEOTIDE COMPOUNDS AS STING AGONISTS
|
|
US20190185509A1
(en)
|
2017-12-20 |
2019-06-20 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
2'2' cyclic dinucleotides with phosphonate bond activating the sting adaptor protein
|
|
WO2019123339A1
(en)
|
2017-12-20 |
2019-06-27 |
Institute Of Organic Chemistry And Biochemistry Ascr, V.V.I. |
2'3' cyclic dinucleotides with phosphonate bond activating the sting adaptor protein
|
|
CA3099421C
(en)
*
|
2018-05-04 |
2025-05-06 |
Tagworks Pharmaceuticals B.V. |
COMPOUNDS INCLUDING A BINDER TO INCREASE TRANSCYCLOOCTENE STABILITY
|
|
WO2021007160A1
(en)
|
2019-07-05 |
2021-01-14 |
Tambo, Inc. |
Trans-cyclooctene bioorthogonal agents and uses in cancer and immunotherapy
|
|
CN110496233B
(zh)
|
2019-09-05 |
2022-07-19 |
复旦大学附属中山医院 |
一种spect显像剂及其标记前体及其制备方法、组合物和用途
|